Nanoparticle Formulation Symposium special issue

We are delighted to announce the launch of a new special issue in RSC Pharmaceutics to celebrate the 2nd Nanoparticle Formulation Symposium, titled Advancing Nanoparticles by Design: From Formulation to Translation.

Hosted by Croda, the Nanoparticle Formulation Symposium will take place at the Royal Society of Chemistry’s Burlington House in London on the 26-27th November 2026, bringing together global academic and industry experts in nanoparticle formulation.

All conference attendees are invited to contribute to this special issue. This special issue will highlight advances in the design and development of nanoparticles for drug delivery and pharmaceutical applications. It will encompass research spanning formulation and physicochemical characterisation, novel materials and manufacturing approaches, drug and biologic delivery, targeting and biological performance, through to preclinical and clinical translation. Particular emphasis will be placed on innovative formulation strategies that improve the performance, stability, manufacturability and translation of nanoparticle-based medicines.

Led by Editor-in-Chief Professor Yvonne Perrie and our brilliant board members, RSC Pharmaceutics is a gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. In order to view any deals that your institute may have in place with the Royal Society of Chemistry for Open Access publishing, or to discover any discounts that you may be entitled to, authors are encouraged to use our Journal Finder tool.

Submit to the Advancing Nanoparticles by Design: From Formulation to Translation special issue RSC Pharmaceutics today! 

Note: When submitting a manuscript to this special issue, please answer ‘yes‘ when asked if it is part of a themed collection on ScholarOne, and input the title as ‘Advancing Nanoparticles by Design: From Formulation to Translation’ in order to link your submission to the issue.

On behalf of the Guest Editors,

Dr Talia Shmool (Imperial College London)

Alex Kramer (Croda Pharma)

Professor Yvonne Perrie (University of Strathclyde)

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.